ADVANCED PANCREATIC CANCER
Clinical trials for ADVANCED PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus injection fights tough pancreatic tumors in new trial
Disease control Recruiting nowThis study tests a new treatment called hV01, a virus modified to attack cancer cells and boost the immune system. It is for 12 people with advanced pancreatic cancer that has not responded to standard treatments. The goal is to see if the virus can shrink tumors and control the …
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
New immune combo targets hard-to-treat pancreatic cancer
Disease control Recruiting nowThis early-phase study tests a combination of two immune cell therapies (activated dendritic cells and CAR-T cells) in 10 people with advanced pancreatic cancer. The goal is to see if this approach is safe and can help the immune system better recognize and attack tumors. Partici…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 11:32 UTC
-
New hope for pancreatic cancer: drug combo trial begins
Disease control Recruiting nowThis study tests a new drug called LM-108 combined with standard chemotherapy for people with advanced pancreatic cancer. The goal is to see if the combination is safe and can slow cancer growth. About 72 adults with advanced disease will take part.
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:30 UTC
-
Personalized medicine hope for pancreatic cancer patients
Knowledge-focused Recruiting nowThis study aims to find genetic changes in the tumors of 750 people with advanced or metastatic pancreatic cancer. By identifying these changes, doctors hope to match patients with targeted treatments that may work better for them. The study does not test a new drug but collects …
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: NA • Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC